搜索临床试验以:Canagliflozin, Advanced CKD, ESRD, Hemodialysis, Peritoneal dialysis, Cardiac MRI, SGLT-2 inhibitors
总计142178个结果
-
Xuanwu Hospital, BeijingPeking University People's Hospital; Chinese PLA General Hospital未知
-
Samsung Medical Center招聘中
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
Azienda Ulss 2 Marca Trevigiana邀请报名
-
Incyte Corporation终止
-
Johannes Gutenberg University Mainz完全的
-
University of Sao Paulo General Hospital招聘中冠状动脉疾病 | 2型糖尿病 | 急性肾损伤巴西
-
University of BirminghamUniversity College, London; National Institute for Health Research, United Kingdom招聘中
-
NovavaxCoalition for Epidemic Preparedness Innovations完全的
-
Jichi Medical UniversityEli Lilly and Company; Boehringer Ingelheim完全的
-
Novo Nordisk A/S完全的2型糖尿病 | 糖尿病美国, 俄罗斯联邦, 加拿大, 奥地利, 日本, 挪威, 波多黎各
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...尚未招聘
-
Eli Lilly and Company招聘中2型糖尿病美国, 日本, 中国, 波多黎各, 罗马尼亚, 巴西
-
Pathalys PharmaLaunch Therapeutics招聘中
-
Azienda Sanitaria OspedalieraCardiologia 2 - Emodinamica - Ospedale Maggiore, Novara, Italy终止
-
Institute of Oncology Ljubljana未知
-
Chinese PLA General Hospital未知
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的肾盂和输尿管转移性移行细胞癌 | 复发性膀胱癌 | 肾盂和输尿管的复发性移行细胞癌 | 肾盂和输尿管区域性移行细胞癌 | III期膀胱癌 | IV 期膀胱癌 | 膀胱移行细胞癌加拿大